Akshara Raghavendra1, Arup K Sinha1,2, Huong T Le-Petross3, Naveen Garg3, Limin Hsu1, Modesto Patangan1, Therese Bartholomew Bevers4, Yu Shen5, Arun Banu1, Debu Tripathy1, Isabelle Bedrosian4, Carlos H Barcenas1. 1. Division of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 2. Department of Biostatistics, The University of Texas School of Public Health, Houston, Texas. 3. Division of Diagnostic Imaging, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 4. Division of Cancer Medicine, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 5. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abstract
BACKGROUND: Women with dense mammographic breast density (BD) have a 2-fold increased risk of developing primary breast cancer (BC). The authors hypothesized that dense mammographic BD also is associated with an increased risk of developing contralateral breast cancer (CBC). METHODS: Among female patients treated at The University of Texas MD Anderson Cancer Center for sporadic, AJCC stage I to stage III BC between January 1997 and December 2012, the authors identified patients who had developed metachronous CBC (cases) and selected 1:2 matched controls who did not develop CBC using incidence density sampling, matched on attainted age, year of diagnosis, and hormone receptor status of the first BC. Mammographic BD, assessed at the time of first BC diagnosis, was categorized as "nondense" (American College of Radiology breast categories of fatty or scattered density) or "dense" (American College of Radiology categories of heterogeneously dense or extremely dense). Multivariable conditional logistic regression models were used for statistical analysis. RESULTS: A total of 229 cases and 451 controls were evaluated. Among the cases, approximately 39.3% had nondense breast tissue and 60.7% had dense breast tissue. Among controls, approximately 48.3% had nondense breast tissue and 51.7% had dense breast tissue. After adjustment for potential prognostic risk factors for BC, the odds of developing CBC were found to be significantly higher for patients with dense breasts (odds ratio, 1.80; 95% confidence interval, 1.22-2.64 [P<.01]) than for those with nondense breasts. Patients who received chemotherapy or endocrine therapy were less likely to develop CBC. CONCLUSIONS: In women with primary BC, mammographic BD appears to be a risk factor for the development of CBC. Cancer 2017;123:1935-1940.
BACKGROUND:Women with dense mammographic breast density (BD) have a 2-fold increased risk of developing primary breast cancer (BC). The authors hypothesized that dense mammographic BD also is associated with an increased risk of developing contralateral breast cancer (CBC). METHODS: Among female patients treated at The University of Texas MD Anderson Cancer Center for sporadic, AJCC stage I to stage III BC between January 1997 and December 2012, the authors identified patients who had developed metachronous CBC (cases) and selected 1:2 matched controls who did not develop CBC using incidence density sampling, matched on attainted age, year of diagnosis, and hormone receptor status of the first BC. Mammographic BD, assessed at the time of first BC diagnosis, was categorized as "nondense" (American College of Radiology breast categories of fatty or scattered density) or "dense" (American College of Radiology categories of heterogeneously dense or extremely dense). Multivariable conditional logistic regression models were used for statistical analysis. RESULTS: A total of 229 cases and 451 controls were evaluated. Among the cases, approximately 39.3% had nondense breast tissue and 60.7% had dense breast tissue. Among controls, approximately 48.3% had nondense breast tissue and 51.7% had dense breast tissue. After adjustment for potential prognostic risk factors for BC, the odds of developing CBC were found to be significantly higher for patients with dense breasts (odds ratio, 1.80; 95% confidence interval, 1.22-2.64 [P<.01]) than for those with nondense breasts. Patients who received chemotherapy or endocrine therapy were less likely to develop CBC. CONCLUSIONS: In women with primary BC, mammographic BD appears to be a risk factor for the development of CBC. Cancer 2017;123:1935-1940.
Authors: M Freedman; J San Martin; J O'Gorman; S Eckert; M E Lippman; S C Lo; E L Walls; J Zeng Journal: J Natl Cancer Inst Date: 2001-01-03 Impact factor: 13.506
Authors: Victoria A Kirsh; Anna M Chiarelli; Sarah A Edwards; Frances P O'Malley; Rene S Shumak; Martin J Yaffe; Norman F Boyd Journal: J Natl Cancer Inst Date: 2011-05-03 Impact factor: 13.506
Authors: Babette Siebold Saltzman; Kathleen E Malone; Jean A McDougall; Janet R Daling; Christopher I Li Journal: Breast Cancer Res Treat Date: 2012-08-19 Impact factor: 4.872
Authors: Lisbeth Bertelsen; Leslie Bernstein; Jørgen H Olsen; Lene Mellemkjaer; Robert W Haile; Charles F Lynch; Kathleen E Malone; Hoda Anton-Culver; Jane Christensen; Bryan Langholz; Duncan C Thomas; Colin B Begg; Marinela Capanu; Bent Ejlertsen; Marilyn Stovall; John D Boice; Roy E Shore; Jonine L Bernstein Journal: J Natl Cancer Inst Date: 2007-12-25 Impact factor: 13.506
Authors: Brian L Sprague; Ronald E Gangnon; Veronica Burt; Amy Trentham-Dietz; John M Hampton; Robert D Wellman; Karla Kerlikowske; Diana L Miglioretti Journal: J Natl Cancer Inst Date: 2014-09-12 Impact factor: 13.506
Authors: Maria E C Sandberg; Jingmei Li; Per Hall; Mikael Hartman; Isabel dos-Santos-Silva; Keith Humphreys; Kamila Czene Journal: Breast Cancer Res Date: 2013 Impact factor: 6.466
Authors: Michael S Shawky; Cecilia W Huo; Kara Britt; Erik W Thompson; Michael A Henderson; Andrew Redfern Journal: Breast Cancer Res Treat Date: 2019-06-08 Impact factor: 4.872
Authors: Marzana Chowdhury; David Euhus; Maureen O'Donnell; Tracy Onega; Pankaj K Choudhary; Swati Biswas Journal: Breast Cancer Res Treat Date: 2018-03-06 Impact factor: 4.872
Authors: Saraswoti Khadge; Geoffrey M Thiele; John Graham Sharp; Timothy R McGuire; Lynell W Klassen; Paul N Black; Concetta C DiRusso; Leah Cook; James E Talmadge Journal: Clin Exp Metastasis Date: 2018-10-16 Impact factor: 5.150
Authors: Karen J Wernli; Rebecca E Smith; Louise M Henderson; Wenyan Zhao; Danielle D Durham; Karen Schifferdecker; Celia Kaplan; Diana S M Buist; Karla Kerlikowske; Diana L Miglioretti; Tracy Onega; Nila H Alsheik; Brian L Sprague; Gloria Jackson-Nefertiti; Jill Budesky; Dianne Johnson; Anna N A Tosteson Journal: Breast Cancer Res Treat Date: 2022-06-20 Impact factor: 4.624
Authors: Gordon P Watt; Julia A Knight; Tuong L Nguyen; Anne S Reiner; Kathleen E Malone; Esther M John; Charles F Lynch; Jennifer D Brooks; Meghan Woods; Xiaolin Liang; Leslie Bernstein; Malcolm C Pike; John L Hopper; Jonine L Bernstein Journal: Int J Cancer Date: 2022-04-04 Impact factor: 7.316
Authors: Jie Ding; Alison T Stopeck; Yi Gao; Marilyn T Marron; Betsy C Wertheim; Maria I Altbach; Jean-Philippe Galons; Denise J Roe; Fang Wang; Gertraud Maskarinec; Cynthia A Thomson; Patricia A Thompson; Chuan Huang Journal: J Magn Reson Imaging Date: 2018-04-06 Impact factor: 4.813
Authors: Julia A Knight; Kristina M Blackmore; Jing Fan; Kathleen E Malone; Esther M John; Charles F Lynch; Celine M Vachon; Leslie Bernstein; Jennifer D Brooks; Anne S Reiner; Xiaolin Liang; Meghan Woods; Jonine L Bernstein Journal: Breast Cancer Res Date: 2018-03-22 Impact factor: 6.466